Holds 4 active US DMFs and 2 valid CEPs for cefuroxime, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 4 active US DMFs and 2 valid CEPs for cefuroxime, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds 3 active US DMFs for cefuroxime, filing since 2000. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds 2 active US DMFs for cefuroxime, filing since 2010. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for cefuroxime, filing since 2004. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for cefuroxime, filing since 2007. Its GMP is recognised in 5 markets.
Holds 4 active US DMFs for cefuroxime, filing since 2008. Its GMP is recognised in 6 markets.
Holds one active US DMF for cefuroxime, filing since 2016. Its GMP is recognised in 1 market.
Holds 9 active US DMFs for cefuroxime, filing since 2008. Its 2015 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Cefuroxime manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free